发明名称 ARGINASE INHIBITORS AND METHODS OF USE THEREOF
摘要 PROBLEM TO BE SOLVED: To provide arginase enzyme inhibitors for treating or diagnosing conditions characterized either by abnormally high arginase activity or abnormally low nitric oxide levels in a mammal.SOLUTION: An inhibitor comprises a composition comprising an alpha-amino acid compound, or a derivative thereof, or a salt thereof, wherein a first substituent and a second substituent are linked to the alpha-carbon of the compound. The first substituent comprises a moiety selected from the group consisting of a boronic acid and N-hydroxy guanidine. The second substituent comprises a proximal nitrogen atom, wherein: the proximal nitrogen is basic; and the proximal nitrogen is separated from the alpha-carbon by a chain of two, three or four carbons, with the proviso that the compound is not 2-amino-6-borono-2-(3-(piperazin-1-yl)propyl)hexanoic acid, 2-(3-(4-acetylpiperazin- 1-yl)propyl)-2-amino-6-boronohexanoic acid, and the like.SELECTED DRAWING: Figure 4
申请公布号 JP2016117735(A) 申请公布日期 2016.06.30
申请号 JP20150252736 申请日期 2015.12.25
申请人 CORRIDOR PHARMACEUTICALS INC 发明人 BRUCE EDWARD TOMCZUK;GARY LEE OLSON;RICHARD SCOTT POTTORF;WANG JANE;BHASKARA RAO NALLAGANCHU
分类号 C07F5/02;A61K31/69;A61P1/04;A61P7/02;A61P7/08;A61P9/00;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P13/12;A61P15/00;A61P15/06;A61P15/10;A61P17/02;A61P17/06;A61P25/00;A61P29/00;A61P31/00;A61P35/00;A61P37/02;A61P37/06;A61P43/00;C07J43/00 主分类号 C07F5/02
代理机构 代理人
主权项
地址